About
49.44USD+2.13 +4.50%
Closed • Updated at 11:13 GMT+00:00Market Cap$1.47B
Volume913.0K
Beta1.01
RSI47.82
Gross Margin64.90%
Genedx Holdings Corp. — investor relations, events, news, and company updates on 6ix.
Latest News
Yesterday
GeneDx to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
May 4 2026
GeneDx Reports First Quarter 2026 Financial Results and Updates Full-Year Outlook
Apr 13 2026
GeneDx to Report First Quarter 2026 Financial Results on Monday, May 4, 2026
Mar 11 2026
Landmark Study Shows Average Cost Savings of $80,000 Per Child and Overall Improved Health Outcomes Following GeneDx Exome and Genome Testing
Mar 10 2026
GeneDx to Launch Genetic Testing Program with Zevra Therapeutics to Support Patients with Suspected Niemann-Pick Disease Type C
Recent Videos

How to use a GeneDx Buccal Swab Kit
May 18, 2026

GeneDx (WGS): 🧬 The Genomic Efficiency Gap
May 18, 2026

$13.8M Into WGS | May 16, 2026 #Shorts
May 18, 2026

GeneDx Holdings Q1 2026 Analysis: The WGS Reimbursement Reset WGS $WGS #WGS #stockmarket
May 06, 2026
Community Chat
Ask AI
Try asking
Google Übersetzer